Deep Radiomics-based Fusion Model Predicting Bevacizumab Treatment Response and Outcome in Patients With Colorectal Liver Metastases

Conditions

• The Patients With CRLM Who Benefit More From Bevacizumab

Interventions

• DIAGNOSTIC_TEST: Deep radiomics-based fusion model

Sponsor

Fudan University